Follow The Filings

HR Healthcare Realty Trust

Real Estate, filed as HEALTHCARE RLTY TR (CL A COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q3, sold by 1

  • 2 Owners
  • Max 0.1%
  • $40M
  • 1 new 1 exit

In 2026 Q3 Lee Ainslie opened a position in Healthcare Realty Trust, while Starboard Value sold out.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Richard Pzena, Pzena Investment Management). Not free-float ownership.

  1. Richard Pzena 0.12%
  2. Lee Ainslie New 0.01%

Who owns HR

Sorted by value, long equity only, as of 2026 Q3.

History
Richard Pzena, Pzena Investment Management 0.12% Hold 2,225,430 $39M History
Lee Ainslie, Maverick Capital 0.01% New 0.01% 39,855 $707K History
Starboard Value exited 2026 Q3 Last 2026 Q2 0.86% Exit −0.86% 1,936,267 $39M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by HR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HR insider trades
  • $181K bought by 2 insiders
  • $926K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Robert E. Hull COO
    Sale
    $401K 21,000 shares at $19.11 7.1% of stake
    Traded Sep 8 Filed Sep 9
  2. Amanda L. Callaway SVP & Chief Accounting Officer
    Sale
    $525K 25,767 shares at $20.37 19% of stake
    Traded Jun 23 Filed Jun 23
  3. Thomas N. Bohjalian Director
    Buy
    $181K 10,000 shares at $18.09 +13% to stake
    Traded Mar 6 Filed Mar 6
  4. Daniel Gabbay CFO
    Buy
    $187 10 shares at $18.74 New stake
    Traded Mar 4 Filed Mar 5

Also filed in the last 12 months, not counted as buying or selling: 24 share withholdings for taxes and 14 stock grants.

Congress

No member of Congress reported trading HR in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02,7.01,9.01
424B5
8-K 8.01,9.01
8-K 2.02,7.01,9.01
10-Q
8-K 5.07
8-K 1.01,2.03,9.01
8-K 1.01,2.03,3.02,9.01
8-K 8.01,9.01
10-Q
SCHEDULE 13G —
8-K 2.02,7.01,9.01
SCHEDULE 13G —
DEF 14A
DEFA14A
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 4.01,9.01
10-K
8-K 2.02,7.01,9.01
SCHEDULE 13G —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $17.45M $19.16M $28.22M
Net income -$278.26M -$654.48M -$246.07M
Net margin * -1594.5% -3416.4% -872.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $12.64B $10.65B $9.21B
Total equity $6.82B $5.23B $4.62B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $499.82M $501.62M $457.1M
Cash from investing $349.14M $900.92M $710.83M
Cash from financing -$0.884B -$1.36B -$1.21B
Net change in cash -$35.26M $43.22M -$42.74M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf